TR RT GHK-CU US, UK, multiple warehouses, CAT IPA10 Retatrutide BPC SM TB500 885340-08-9
TDS 36 Inquiries
885340-08-9
Pharmaceutical Grade
99%
Hong Kong
customizable
10vials/box
2027-12-03
Tirzepatide,Retatrutide,Survodutide,GHK-CU,GLOW,KLOW
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceTB 500 is a synthetically made version of TB4 that facilitates healing and recovery by helping build new blood vessels, muscle tissue fibers, blood cells, and facilitating cell migration. It acts on the muscular system and has anabolic properties. TB 500 is used primarily for race animals (horses and dogs).Certificates
-
TDS
Basic Info-
Product Name:
TB500
Other Name:TB500 fragment;L-Glutamine, N-acetyl-L-leucyl-L-lysyl-L-lysyl-L-threonyl-L-α-glutamyl-L-threonyl-;Thymosin Beta 4 Peptide Peptides Tb500 2mg/Vials 5mg/Vials;TB500 fragment acetate;TB500 Thymosin Beta 4 (TB4);Ac-LKKTETQ;Thymosin β4 TB500;TB500(Thymosin B4 AceTate) 5MG 10MG
CAS No.:885340-08-9
Molecular Formula:C38H68N10O14
InChIKeys:ADKDNDYYIZUVCZ-HLXZCORBNA-N
Molecular Weight:889.02
EC Number:232-660-2
Color/Form:White to Off-White
Categories:
Characteristics-
Density:
1.281±0.06 g/cm3(Predicted)
Boiling Point:1405.0±65.0 °C(Predicted)
PKA:3.20±0.10(Predicted)
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Survodutide,GHK-CU,GLOW,KLOW
-
Location:
Building 1, Floor 2, No. 96 Banhe Road, Huangpu District, Guangzhou City, Room 2164
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
12
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
Certifications:
COA,COA,COA,COA,COA,COA,COA,COA,COA
"> -
-
Inquiry History36 Inquiries
Country Product Purchase Quantity Date Posted
United States
Factory price CAS 885340-08-9 L-Glutamine TB500
1 KG Sep 26, 2023
United States
TB500 99% White powder Beta-4 CAS 885340-08-9 powder Custom peptides
1000 Oct 30, 2023
United States
TB 500
150 MG Apr 8, 2026
United States
China Origin TB500 2mg/5mg/10mg Lyophilized Powder for the Wound Repair Research
1 G Mar 26, 2026
United States
TB500
100 MG Feb 27, 2026
Germany
TB 500
1 KG Feb 8, 2026
Portugal
Tb 500
10 MT Aug 7, 2024
France
TB500
1 KG Mar 27, 2024
United States
TB500
1 G Jan 27, 2024
Brazil
TB-500
1 G Jun 18, 2026
Canada
TB 500
1 KG May 8, 2026
United States
TB 500
20 G Feb 23, 2026
Brazil
alejandro
300 PCS Feb 19, 2026
United States
TB500 10mg
1 MT Oct 20, 2025
United States
Tesomorelin
1 KG Aug 8, 2025
Italy
TB500
1000 MG Dec 30, 2024
Netherlands
tb500
1 Dec 16, 2024
New Zealand
TB500
100 MG Jun 24, 2024
Germany
High Purity 99% Tb-500 5mg TB 500 Peptide TB500
1 MT Oct 19, 2023
United States
High Purity 99% Tb-500 5mg TB 500 Peptide TB500
10 MT Oct 12, 2023 Post an enquiry for this product
